Published in

American Society of Hematology, Blood, 1(132), p. 89-100

DOI: 10.1182/blood-2017-11-814244

Links

Tools

Export citation

Search in Google Scholar

Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Key Points Whole-exome sequencing may identify specific therapeutic opportunities for patients with HLH. HLH should be conceptualized as a critical illness phenotype driven by toxic activation of immune cells from different underlying mechanisms.